Hepatic Hydrothorax
A pleural effusion (>500 mL) in a patient with cirrhosis and portal hypertension, without primary cardiac or pulmonary disease.
🔍 Definition:
Hepatic hydrothorax is a transudative pleural effusion, typically right-sided, occurring in patients with decompensated liver cirrhosis and ascites, though it can occasionally occur without ascites.
📊 Epidemiology:
- Occurs in 5–10% of patients with cirrhosis.
- 85% are right-sided, 13% left-sided, 2% bilateral.
- Can be large and recurrent, leading to dyspnea and respiratory failure.
🔬 Pathophysiology:
|
Step |
Explanation |
|
1. Portal hypertension |
Leads to ascites due to increased hydrostatic pressure and low oncotic pressure (↓ albumin). |
|
2. Diaphragmatic defects |
Small fenestrations (congenital/acquired) allow ascitic fluid to pass into pleural space. |
|
3. Negative intrathoracic pressure |
Promotes unidirectional flow from peritoneum to pleural cavity. |
|
4. One-way valve effect |
Fluid accumulates more in pleural space, even when ascites is minimal. |
🧪 Clinical Features:
- Dyspnea (often disproportionate to ascites)
- Non-productive cough
- Orthopnea or platypnea
- Chest discomfort or pleuritic pain
- Decreased breath sounds, dullness to percussion
- Signs of decompensated liver disease (ascites, jaundice, encephalopathy)
📷 Investigations:
1. Imaging:
|
Modality |
Findings |
|
Chest X-ray |
Massive unilateral effusion (usually right), mediastinal shift |
|
USG Thorax |
Confirms effusion, helps with thoracentesis guidance |
|
CT Thorax |
Excludes malignancy, TB, or pulmonary causes |
|
Tc-99m peritoneal scintigraphy |
Shows flow of ascitic fluid into pleural space via defects |
2. Pleural Fluid Analysis (via thoracentesis)
|
Parameter |
Finding in Hepatic Hydrothorax |
|
Appearance |
Clear/straw-colored |
|
Protein |
<2.5 g/dL (transudate) |
|
LDH |
Low (<0.6 serum LDH) |
|
pH |
>7.4 (normal or slightly alkaline) |
|
Glucose |
Normal |
|
Cell count |
<250 cells/mm³; lymphocyte or mesothelial predominant |
|
Culture |
Sterile unless infected (→ spontaneous bacterial empyema) |
Note: 5–10% may show atypical exudative pattern due to repeated procedures or infection.
Management
A. Medical Management
|
Step |
Intervention |
|
1. Sodium restriction |
<2 g/day |
|
2. Fluid restriction |
Especially if hyponatremia |
|
3. Diuretics |
Spironolactone ± furosemide (watch renal function) |
|
4. Therapeutic thoracentesis |
For symptomatic relief; avoid >1.5 L per tap |
|
5. Albumin infusion |
If large-volume paracentesis or low serum albumin |
|
6. Avoid NSAIDs, nephrotoxins |
To prevent hepatorenal syndrome |
B. Definitive Management
|
Option |
Indication |
|
TIPS (Transjugular Intrahepatic Portosystemic Shunt) |
Refractory hydrothorax unresponsive to medical therapy |
|
Pleurodesis |
Often fails due to continuous fluid transfer; rarely effective |
|
Surgical repair of diaphragm |
For isolated large defects (rare) |
|
Liver transplantation |
Definitive treatment |
⚠️ Complications
- Spontaneous bacterial empyema (SBEM) – similar to SBP, may occur even without pneumonia
- Respiratory distress
- Tension hydrothorax (rare)
- Infection post-thoracentesis
- Electrolyte imbalance and renal dysfunction due to aggressive diuresis
🧪 Spontaneous Bacterial Empyema (SBEM)
|
Parameter |
Diagnostic Criteria (in hepatic hydrothorax) |
|
PMN count |
>250 cells/mm³ |
|
Culture |
Positive without pneumonia |
|
Treatment |
Cefotaxime/Ceftriaxone + albumin ± chest tube (if purulent) |
🔍 Differential Diagnosis
- Malignant pleural effusion
- Tubercular effusion
- Parapneumonic effusion/empyema
- Congestive heart failure
- Chylothorax
- Nephrotic syndrome-related effusion

